Moreover, both in vitro and in vivo studies further confirmed that PRAME can facilitate the proliferation, migration, invasion, and EMT of LSCC cells and promote tumor growth, at least partially by activating PI3K/AKT/mTOR pathways (Figure 7). The gene discussed is MTOR; the disease is neoplasm.